ALFIKI, M. M., H. S. El-Abhar, D. M. Abdallah, and L. I. N. A. E. KHEDR, "The Efficacy and Safety of Treatment of Chronic HCV Infection by Ombitasvir/Paritaprevir/Ritonavir with Ribavirin and its Effect on Complement C3 and C4 Levels", Med. J. Cairo Univ. , vol. 90, pp. 65-72, 2022.
Ashmawy, A. I., H. S. El-Abhar, D. M. Abdallah, and M. A. Ali, "Chloroquine modulates the sulforaphane anti-obesity mechanisms in a high-fat diet model: Role of JAK-2/ STAT-3/ SOCS-3 pathway", Eur J Pharmacol , vol. 927, pp. 175066, 2022.
Tawfiq, R. A., N. N. Nassar, O. A. Hammam, R. M. Allam, M. M. Elmazar, D. M. Abdallah, and Y. M. Attia, "Obeticholic acid orchestrates the crosstalk between ileal autophagy and tight junctions in non-alcoholic steatohepatitis: Role of TLR4/TGF-β1 axis", Chem Biol Interact , pp. 109953, 2022.
El-Emam, M. A., S. E. Achy, D. M. Abdallah, H. S. El-Abhar, and M. A. Gowayed, "Does physical exercise improve or deteriorate treatment of multiple sclerosis with mitoxantrone? Experimental autoimmune encephalomyelitis study in rats", BMC Neurosci . , vol. 23, issue (1), pp. 11, 2022.
Abdel-Latif, R. T., W. Wadie, Y. Abdel-Mottaleb, D. M. Abdallah, N. N. El-Maraghy, and H. S. El-Abhar, "Reposition of the anti-inflammatory drug diacerein in an in-vivo colorectal cancer model", Saudi Pharmaceutical Journal, vol. 30, pp. 72–90, 2022.
Kamel, N. M., D. M. El-Tanbouly, D. M. Abdallah, and H. M. Sayed, "PAR1, a therapeutic target for remote lung injury associated with hind limb ischemia/reperfusion: ERK5/KLF2-dependent lung capillary barrier preservation", Chemico-Biological Interactions, vol. 354, pp. 109809, 2022.
Ghaith, W. Z., N. N. Nassar, E. A. Mobarez, and D. M. Abdallah, "THE WIN55, 212-2 ENIGMA IN A RESERPINE INDUCED PARKINSON MODEL", WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, vol. 9, issue 7, pp. 2282-2301, 2020.
Yehia, R., M. Schaalan, D. M. Abdallah, A. S. Saad, N. Sarhan, and S. Saleh, "Impact of TNF-α Gene Polymorphisms on Pancreatic and Non-Small Cell Lung Cancer-Induced Cachexia in Adult Egyptian Patients: A Focus on Pathogenic Trajectories", Frontiers in Oncology, vol. 11, pp. 783231, 2021.
Zaky, D. A., W. M. Eldehna, A. E. M. Kerdawy, D. M. Abdallah, H. E. S. Abhar, and W. Wadie, "Recombinant human growth hormone improves the immune status of rats with septic encephalopathy: The role of VEGFR2 in the prevalence of endoplasmic reticulum stress repair module", International Immunopharmacology, vol. 101, issue Part B, pp. 108370, 2021.